{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:22:32Z","timestamp":1768519352285,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31972692"],"award-info":[{"award-number":["31972692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB520"],"award-info":[{"award-number":["2020CFB520"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF21C010001"],"award-info":[{"award-number":["LGF21C010001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["202003N4010"],"award-info":[{"award-number":["202003N4010"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.054","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:37:10Z","timestamp":1661740630000},"page":"5757-5763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody"],"prefix":"10.1016","volume":"40","author":[{"given":"Xiaoling","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6485","key":"10.1016\/j.vaccine.2022.08.054_b0005","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.vaccine.2022.08.054_b0010","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7830","key":"10.1016\/j.vaccine.2022.08.054_b0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0020","article-title":"RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23942-y","article-title":"SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung","volume":"12","author":"Routhu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"issue":"6530","key":"10.1016\/j.vaccine.2022.08.054_b0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2022.08.054_b0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41422-022-00631-z","article-title":"A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0045","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1080\/22221751.2021.1959270","article-title":"Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19","volume":"10","author":"Xu","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.054_b0050","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1080\/21645515.2020.1840887","article-title":"Vaccinia virus-based vector against infectious diseases and tumors","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"25","key":"10.1016\/j.vaccine.2022.08.054_b0055","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2019.04.070","article-title":"Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice","volume":"37","author":"Xie","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.054_b0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/vim.2019.0164","article-title":"Administration with Vaccinia Virus Encoding Canine Parvovirus 2 vp2 Elicits Systemic Immune Responses in Mice and Dogs","volume":"33","author":"Zhao","year":"2020","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2022.08.054_b0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2021.02.010","article-title":"SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter","volume":"558","author":"Xie","year":"2021","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2022.08.054_b0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0969-2126(97)00233-5","article-title":"Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain","volume":"5","author":"Tao","year":"1997","journal-title":"Structure"},{"issue":"9","key":"10.1016\/j.vaccine.2022.08.054_b0075","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","article-title":"Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","volume":"27","author":"Huo","year":"2020","journal-title":"Nat Struct Mol Biol"},{"issue":"7898","key":"10.1016\/j.vaccine.2022.08.054_b0080","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/22221751.2021.2023330","article-title":"Omicron: a drug developer's perspective","volume":"11","author":"Fang","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.08.054_b0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.1500198","article-title":"Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge","volume":"195","author":"Yan","year":"2015","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.054_b0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/v14020187","article-title":"Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2022.08.054_b0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:52Z","timestamp":1759403752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22010441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":20,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X22010441"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}